[ad_1]
(Photo credit should read GEOFFROY VAN DER HASSELT / AFP / Getty Images)
Mice with pancreatic cancer treated with a combination of cannabidiol (CBD) and chemotherapy have survived almost three times longer than those treated with chemotherapy alone, according to a new study that highlights the potential for human treatment.
CBD, the non-psychoactive compound (non-intoxicant) in cannabis, has already been shown to improve chemotherapy side effects such as nausea and vomiting: the most recent results warrant further testing in the US. man, based on previous research on animals that have discovered possible anticancer properties of the compound.
"Cannabidiol is already clinically approved [in the UK]which means that we can quickly test this data as part of clinical trials on humans," said lead researcher Marco Falasca. Queen Mary University of London
Although human trials involving CBD as a treatment for cancer may progress more rapidly in the United Kingdom, similar efforts may encounter barriers in the United States, where CBD Cannabis derivative is still considered an illegal substance.
The most lethal forms of cancer in the world in terms of overall survival rate. According to the American Cancer Society, for all stages of pancreatic cancer combined , the one-year relative survival rate is 20% and the five-year rate is just under 7% .These are the 12 most prevalent cancers in the world, with the incidence the highest in developed countries.
"The life expectancy of pancreatic cancer patients has barely changed in the last 40 years. "Given that the five-year survival rate for people with pancreatic cancer is less than seven percent, the discovery of new treatments and therapeutic strategies is urgent," Dr. Falasca added in a press release.
Although this study has not yet been replicated in humans, the results underscore the importance of continuing research on marijuana compounds. As we have seen since the beginning of the legalization movement, studies have linked compounds to multiple promising results, ranging from alleviating migraine symptoms to improving stroke recovery to the decreasing severity of crises, among others
. of these compounds, the more it seems clear that decades of research blocked by federal law have robbed us of medical advances that are just beginning to surface.
The study was published in the journal Oncogene . 19659003] You can find David DiSalvo on Twitter Facebook, Google Plus and on his Web site, daviddisalvo.org GEOFFROY VAN DER HASSELT / AFP / Getty Images)
